Pharmacy benefits and the use of drugs by the chronically ill.
about
The new medicare drug benefit: formularies and their potential effects on access to medicationsAssociation between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancerThe effects of the coverage gap on drug spending: a closer look at Medicare Part DThe impact of the Medicare Part D prescription benefit on generic drug useThe Affordable Care Act and Diabetes Diagnosis and Care: Exploring the Potential ImpactsFinancial incentive increases CPAP acceptance in patients from low socioeconomic backgroundConfounding in the association of proton pump inhibitor use with risk of community-acquired pneumoniaPhysician awareness of drug cost: a systematic reviewDo randomized controlled trials discuss healthcare costs?Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic reviewFunctional Limitations, Medication Support, and Responses to Drug Costs among Medicare BeneficiariesPotential Savings from an Evidence-Based Consumer-Oriented Public Education Campaign on Prescription DrugsMedicare prescription drug coverage: consumer information and preferences.The effect of offering different numbers of colorectal cancer screening test options in a decision aid: a pilot randomized trial.Cost-offsets of prescription drug expenditures: data analysis via a copula-based bivariate dynamic hurdle model.Plan selection in Medicare Part D: evidence from administrative data.Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines.Impact of pharmacy benefit design on prescription drug utilization: a fixed effects analysis of plan sponsor data.Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims dataTrends in patient cost sharing for clinical services used as quality indicators.Can increases in CHIP copayments reduce program expenditures on prescription drugs?Access to oral osteoporosis drugs among female Medicare Part D beneficiaries.The impact of cost sharing on antidepressant use among older adults in British Columbia.Sensitivity of medication use to formulary controls in medicare beneficiaries: a review of the literature.Increased Patient Cost-Sharing, Weak US Economy, and Poor Health Habits: Implications for Employers and Insurers.Perspectives in value-based insurance design for patients with diabetes: assessment and application.Partial compliance with antipsychotics increases mental health hospitalizations in schizophrenic patients: analysis of a national managed care database.The h-e-B value-based health management program: impact on asthma medication adherence and healthcare cost.Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices.Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis.Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project.Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarctionIndividual patients hold different beliefs to prescription medications to which they persist vs nonpersist and persist vs nonfulfill.Medication adherence and use of generic drug therapies.Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patientsEffect of Part D coverage restrictions for antidepressants, antipsychotics, and cholinesterase inhibitors on related nursing home resident outcomesCost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritisAdherence to anti-diabetic drugs among patients with Type 2 diabetes mellitus at Muhimbili National Hospital, Dar es Salaam, Tanzania- A cross-sectional study.Patient Cost-Sharing and Hospitalization Offsets in the Elderly.Pharmaceutical cost management and access to psychotropic drugs: the U.S. context
P2860
Q24540426-31391DD0-620D-485C-B1E4-5F648224843CQ24632347-CF9B4D51-862C-4C2A-9986-631343168A9EQ24632713-E6A3FFA9-32B0-4F46-9C6A-1D471A8E04EBQ24652400-FDC142F2-20BB-4A01-BC98-2E80B0D27D4AQ26764842-687AF628-8448-47F8-B6AC-212CABFEA6AFQ28382933-782382CD-E919-4384-A912-32B8F36D18F7Q28396345-D7D32C66-F777-4016-942C-D33CADE53B75Q28469310-926E966B-DDE4-4029-A67B-FE870AB4813EQ28475247-91A53ACB-AD93-4774-A23E-9529158056D9Q28541457-B6C98DD2-64B0-4C92-B2D4-662A29927AFAQ28551392-C587C1D2-295E-472E-BC2E-8A489BAF6754Q29393270-18E0373E-7F72-40DE-9CE1-F6DE3A597454Q30477378-BD2E088E-D10E-46E2-90C4-0DD4845149D9Q30481376-C230334D-EADB-47B1-A9F5-E18EF5C57FD4Q30662172-672408CB-03F9-4371-8B1A-9EB52BC13FFAQ30708739-CDE8EF5D-9330-42AC-AD37-ADF57477A546Q33355842-5EEEECB5-24B5-4307-9F5C-0A85E06997B9Q33404862-255D5236-6178-4186-851B-30A372D1C0F3Q33630092-CBE65717-3F43-4C2B-89AC-D931C4CC5EAFQ33730870-D5240786-CCE0-493E-88D4-CD909BAA7CE4Q33777338-50A4D2F4-6BFA-42DB-A3BE-0C94292EB27CQ33841382-466718C2-6CFC-4157-85EC-AF7AB78C2CF4Q33908092-3E7B1934-ECBF-45D5-8525-3C0A87AB0C86Q33931960-F0C55A0E-E59E-41C8-BB9E-71D7FD566FBFQ33932255-E3111EF0-91AF-4470-8F00-7B28D888C028Q33932273-5D422606-029C-4118-89C6-5B88E4F866FDQ33932365-B67889AA-F80C-4486-BF60-DBFF1FD536A2Q33932497-C81F4054-0CE7-4A08-A7F0-E16EF10CE771Q33942677-4137582D-E96E-4AE9-BAD5-BD843366AD0EQ33957383-64EA259C-88F6-4767-9E0E-6B2CEE82339AQ33964895-50BC0CEF-B753-4CEB-AEB4-706657F33C6FQ34001855-BDD94BF6-17C6-4F09-BB39-F6BAA493B257Q34041984-2E636528-8457-4087-9C90-DCBB4628096EQ34052798-CDE786A2-3709-49B5-B30A-F4FAE5BE8DA2Q34193946-3A3A0BF0-A10D-4A44-95BA-8C99891FFAAAQ34231952-AE08739F-9F53-430E-8CD3-3F0392E800DFQ34248283-18CD4D96-26C6-4AF8-B29C-EFE58CB39742Q34307167-EC16DE19-5E04-4FD4-8CF9-39C01DD542A7Q34313865-2057C925-3CD5-4B60-A022-2047B359FF83Q34390982-6367D9DA-C7E3-430E-B07E-8D3E2416A18F
P2860
Pharmacy benefits and the use of drugs by the chronically ill.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pharmacy benefits and the use of drugs by the chronically ill.
@en
Pharmacy benefits and the use of drugs by the chronically ill.
@nl
type
label
Pharmacy benefits and the use of drugs by the chronically ill.
@en
Pharmacy benefits and the use of drugs by the chronically ill.
@nl
prefLabel
Pharmacy benefits and the use of drugs by the chronically ill.
@en
Pharmacy benefits and the use of drugs by the chronically ill.
@nl
P2093
P356
P1476
Pharmacy benefits and the use of drugs by the chronically ill.
@en
P2093
Dana P Goldman
Geoffrey F Joyce
Jennifer E Pace
Jose J Escarce
Marianne Laouri
Matthew D Solomon
Pamela B Landsman
Steven M Teutsch
P304
P356
10.1001/JAMA.291.19.2344
P407
P577
2004-05-01T00:00:00Z